Form D · Biotechnology
BRT Biotechnologies, Inc.
Claremont, CA · CIK 0001994719
Offering snapshot reported May 8, 2026 · SEC filing
- Reported sold
- $607K Offering amount: $607K
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 5, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2026 | Initial | $607,300 | No comparison | 12 | SEC filing |
| Oct 26, 2023 | Amendment | $272,500 | $110,000vs Oct 5, 2023 | 7 | SEC filing |
| Oct 5, 2023 | Initial | $162,500 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-583347
Source: Form D, filed May 8, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory Copeland | Director, Executive |
| Jane Liu | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Seaver North 645 N College Ave
Claremont, CA, 91711
Claremont, CA, 91711